SCHEMBL3738396

SCHEMBL3738396

COc1cc2c(cc1OC)-c1c(Cl)nc3ccccc3c1C2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.43
ALDH1A1 P00352 5/20 0.42
HPGD P15428 2/20 0.42
GUSB P08236 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NPC1 O15118 2/20 0.42
ACACA Q13085 1/20 0.42
C1R P00736 1/20 0.42
MAPT P10636 5/20 0.41
POLB P06746 1/20 0.41
NQO2 P16083 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 4/20 0.41
RAB9A P51151 1/20 0.41
USP2 O75604 1/20 0.41
DUSP3 P51452 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CDK4 P11802 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3736581 0.87 NTRK1 (0.51) ALDH1A1GUSBKDM4EPOLBKMT2A
SCHEMBL3732268 0.82 PABPC1 (0.47) ALDH1A1GUSBNPC1C1RMAPT
SCHEMBL16895274 0.82 APAF1 (0.48) GUSBKDM4EC1RMAPTSMN1; SMN2
SCHEMBL7822017 0.82 NTRK1 (0.51) ALDH1A1GUSBKDM4EPOLBKMT2A
SCHEMBL21451028 0.80 TDO2 (0.46) KDM4ENPC1KMT2AMEN1RAB9A
SCHEMBL7811355 0.79 NTRK1 (0.50) GUSBKDM4EACACAPOLBLMNA
SCHEMBL7812699 0.77 ALDH1A1 (0.52) ALOX15ALDH1A1GUSBKDM4ENPC1
SCHEMBL7820606 0.77 MEN1 (0.49) ALDH1A1KDM4ENPC1MAPTPOLB
SCHEMBL16895265 0.76 MAPK1 (0.45) ALDH1A1GUSBKDM4ENPC1MAPT
SCHEMBL12781496 0.76 PABPC1 (0.47) ALDH1A1GUSBNPC1C1RMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7829567-B2 Imino-indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2010-11-09 US disclosed
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same IMPA1, IMPDH1, IPO5 ALOX15 4265/4885ALDH1A1 324/4885HPGD 779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.